Page last updated: 2024-10-23

benzothiazide and Hyperprolactinemia

benzothiazide has been researched along with Hyperprolactinemia in 1 studies

benzothiazide: structure
benzthiazide : 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema.

Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adler, RA1
Costanzo, LS1
Stauffer, ME1

Other Studies

1 other study available for benzothiazide and Hyperprolactinemia

ArticleYear
Hypercalciuria in hyperprolactinemic rats: effects of benzthiazide.
    Metabolism: clinical and experimental, 1986, Volume: 35, Issue:7

    Topics: Animals; Benzothiadiazines; Calcium; Calcium, Dietary; Diuretics; Dose-Response Relationship, Drug;

1986